Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

NCT03995147 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma
Lymphoma
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma

Interventions

DRUG: Pembrolizumab
DRUG: R-CHOP Protocol

Sponsor

University of Chicago

Collaborators

[object Object]